Company intelligence / Profile preview
Yantai Dongcheng Pharmaceutical Group
- Ownership
- Private
- Employees
- ~2469
- Development stage
- Phase 3
Overview
Yantai Dongcheng is a leading Chinese pharmaceutical group specializing in the manufacture and export of biochemical APIs such as heparin sodium and chondroitin sulfate, with significant regulatory certifications including U.S. FDA site audit and European CEP certificates[4][6][8]. The company has expanded into radiopharmaceuticals and finished formulations, with products sold in over 50 countries[4][6].
- Therapeutic areas
- OncologyCardiovascularRheumatologyInfectious Diseases
- Modalities
- Small moleculeProteinPolysaccharide (e.g. heparin, chondroitin sulfate)Radiopharmaceutical
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Yantai Dongcheng Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yantai Dongcheng Pharmaceutical Group.